| 期刊簡介 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY LetPub Score 7.5
51 ratings
Rate
Reputation 8.2 Influence 6.5 Speed 9.7 | ||||||||||||||||||||
| 期刊簡稱 | J ENZYM INHIB MED CH | ||||||||||||||||||||
| ISSN | 1475-6366 | ||||||||||||||||||||
| E-ISSN | 1475-6374 | ||||||||||||||||||||
| h-index | 61 | ||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||
| 自引率 (2023-2024) | 8.90%自引率趨勢 | ||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||
| 官方網站 | http://www.tandfonline.com/loi/ienz20 | ||||||||||||||||||||
| 在線稿件提交 | https://mc.manuscriptcentral.com/genz | ||||||||||||||||||||
| 開放訪問 | Yes | ||||||||||||||||||||
| 出版商 | Informa Healthcare | ||||||||||||||||||||
| 主題領域 | 医学 | ||||||||||||||||||||
| 出版國/地區 | ENGLAND | ||||||||||||||||||||
| 發行頻率 | 隔月刊行 | ||||||||||||||||||||
| 創刊年 | 2002 | ||||||||||||||||||||
| 每年文章數 | 195每年文章數趨勢 | ||||||||||||||||||||
| 黃金OA百分比 | 97.77% | ||||||||||||||||||||
OA Related Info | APC: Yes（ EUR2520; USD2630; GBP2100; ） APC waiver：Check Notes Other charges: No Keywords: enzymology、cell biology、chemical biology、microbiology、physiology、pharmacology Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||
| Web of Science 四分位 （ 2023-2024） | WOS Quartile: Q1
| ||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1475-6366%5BISSN%5D | ||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | ||||||||||||||||||||
| 競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||
| *所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||
|
|
| |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
| [JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY] 的評論 | 撰寫評論 |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-30 11:17:18 評論於 Please translate the following paragraph into English and Japanese, and use ":" and ":" as headers  (0) 讚！ | 维尔娜菲茨杰拉德  |
| 作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-30 08:42:04 評論於 There are many ways to write an introduction, but the general rule is that you only need to describe the problem (0) 讚！ | 维尔娜菲茨杰拉德 |
| 作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-27 19:09:51 評論於 What are the differences between writing an introduction and discussing? (0) 讚！ | 北国博达 |
| 作者: 破戒阳平 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2021-12-26 22:28:10 評論於 Is the introduction generally three paragraphs? (0) 讚！ | 破戒阳平 |
| 作者: 碧波焕焕 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2020-04-19 09:35:08 評論於 How long will the status "Out for Review" last? (0) 讚！ | 碧波焕焕 |
| 作者: 百花芳林 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2019-09-11 14:13:51 評論於 The review speed is very fast, and the first review feedback is received in less than a month (0) 讚！ | 百花芳林 |
| 作者: 中原明智 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2017-07-20 12:51:32 評論於 Review Speed: 3.0 | Submission Success Rate: 50.0 Sharing Experience: Inquiry: Is the study on hydrolytic enzymes and their inhibitor proteins within the scope of this journal? The enzyme has no relationship with medicine. It is a common hydrolytic enzyme used more in industry (0) 讚！ | 中原明智 |
| 作者: 桃花问容 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2016-01-23 18:54:47 評論於 Review Speed: 1.0 Experience Sharing: We received feedback on our submission quickly, but the review of the revised manuscript was slow. After emailing to inquire about the status, we were told that it was accepted (0) 讚！ | 桃花问容 |
| 作者: dani@sit.edu.cn 領域: 生命科学 審稿時間: 1.0 month(s) 結果: 修改後接受 撰寫評論 |
2016-01-23 12:00:45 評論於 We received the review comments shortly after submitting the I initial manuscript, but the review of the revised manuscript has been slow. (0) 讚！ | dani@sit.edu.cn |
| 作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定＆不明 撰寫評論 |
2014-07-30 10:18:07 評論於 Surprise, last year was just over 1 point, this year suddenly over 2 points, but once over 3 points, it is equivalent to passing the threshold, and it will be easier next (0) 讚！ | 凌霄高洁 |
| 首頁 上一頁 1 下一頁 末頁 (頁 | |
Contact us
